-
MARK2 Enzyme May be a Target for Neurodegenerative Disease Treatments
In addition to the MARK2 enzyme having potential relevance to neurodegenerative diseases, the finding is an advance in understanding basic cell biology.
Findings are consistent with the idea that in ALS, this PKCĪ“-MARK2 pathway is highly active and reducing protein production, which over the long term contributes to the disease process.
Another flash in the pan?
Richard
-
0 Replies
Sorry, there were no replies found.
Log in to reply.